Memantine

Memantine hydrochloride is a raw material. It should be prescribed by experienced doctors in the diagnosis and treatment of Alzheimer's dementia and guided by patients. Treatment can only begin when there are caregivers around the patient who regularly supervise the patient's medication. Dementia should be diagnosed in accordance with current diagnostic criteria and guidelines.

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Memantine is clinically used for the treatment of moderate to severe senile dementia and parkinsonism syndrome. It is a new type of anti-senile dementia drug and can be used for the treatment of moderate to severe senile dementia.

Memantine is used to treat moderate-to-severe Alzheimer's disease, especially for people who are intolerant of or have a contraindication to AChE (acetylcholinesterase) inhibitors.One guideline recommends memantine or an AChE inhibitor be considered in people in the early-to-mid stage of dementia.

Memantine has been associated with a modest improvement; with small positive effects on cognition, mood, behavior, and the ability to perform daily activities in moderate-to-severe Alzheimer's disease. There does not appear to be any benefit in mild disease.

Memantine when added to donepezil in those with moderate-to-severe dementia resulted in "limited improvements" in a 2017 review. The UK National Institute of Clinical Excellence (NICE) issued guidance in 2018 recommending consideration of the combination of memantine with donepezil in those with moderate-to-severe dementia. Effects in autism are unclear. Recent scientific journal reports are showing guarded promise with severe obsessive compulsive disorder.

Manana orinasa avo lenta maro miaraka amin'ny fiaraha-miasa lalina, izay afaka manome anao vokatra avo lenta sy ny vidiny mifaninana. Ary afaka manome fihenam-bidy ho an'ny fividianana betsaka ihany koa izahay.Ary miara-miasa amin'ny orinasa mpitatitra entana matihanina maro izahay, afaka manatitra vokatra soa aman-tsara sy milamina amin'ny tananao. Delivery fotoana dia tokony ho 3-20 andro aorian'ny fanamafisana ny fandoavam-bola.

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Memantine HCl is the HCl form of Memantine. Memantine is a well- known neuroprotective drug used for the treatment of Alzheimer's disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European.
The development of Alzheimer's disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity.
Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs).
Memantine is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington's disease, ALS and movement disorders, among other. 

1. Orinasa ve ianao sa orinasa mpivarotra?
Izahay dia compnay mampiditra ny indostria sy ny varotra, manome serivisy tokana. Azo ekena ny OEM.

2. Manome santionany ve ianao? Maimaimpoana ve sa fanampiny?
Santionany maimaim-poana.Ny sandan'ny entana santionany dia mila aloa eo anilanao.

3. Manana taratasy fanamarinana mifandraika amin'ny fanaraha-maso kalitao ve ianao?
ISO 9001: 2008 fanamarinana mba hiantohana ny kalitao.

4. Inona no tokony homeko mba hahazoana teny nindramina?
Pls ampahafantaro anay ny karazana vokatra ilainao, ny habetsaky ny baiko, ny adiresy ary ny fepetra takiana manokana.

5. Inona no fomba fandoavam-bola tianao? Karazana fepetra inona no ekena?
Fepetra fanaterana ekena: FOB, CFR, CIF, EXW;
Vola fandoavana ekena:USD;
Karazana fandoavam-bola ekena: T / T, Western Union; Paypal, Trade Assurance.
Fiteny ampiasaina: Anglisy.